Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
53.29
+0.22 (0.41%)
At close: Nov 6, 2026, 4:00 PM EST
52.49
-0.80 (-1.50%)
After-hours: Nov 6, 2026, 7:30 PM EST
Pulse Biosciences Revenue
Pulse Biosciences had revenue of $395.00K in the quarter ending September 30, 2026, with 359.30% growth. This brings the company's total for the last twelve months to $1.49M, up 1,637.21% year-over-year. In the year 2025, Pulse Biosciences had annual revenue of $350.00K. That makes Pulse Biosciences the 42,997th largest company in the world by revenue and 5,923rd in the United States.
Revenue (ttm)
$1.49M
Revenue Growth
+1,637.21%
P/S Ratio
2,623.44
Revenue / Employee
$12,879
Employees
116
Market Cap
3.92B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 350.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 700.00K | -718.00K | -50.63% |
| Dec 31, 2021 | 1.42M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bausch + Lomb | 5.42B |
| DENTSPLY SIRONA | 3.58B |
| MiniMed Group | 3.22B |
| Envista Holdings | 2.88B |
| Teleflex | 2.26B |
| ICU Medical | 2.18B |
| Merit Medical Systems | 1.61B |
| Stevanato Group | 1.42B |
PLSE News
- 2 days ago - Pulse Biosciences price target raised to $74 from $58 at Canaccord - TheFly
- 2 days ago - Pulse Biosciences price target raised to $65 from $55 at Mizuho - TheFly
- 2 days ago - Pulse Biosciences announces interim results from PRECISE-BTN - TheFly
- 2 days ago - Pulse Biosciences Presents Six-Month Interim Results from the PRECISE-BTN Multicenter Study at the American Thyroid Association Annual Meeting - Business Wire
- 3 days ago - Pulse Biosciences reports Q3 EPS (32c), consensus (29c) - TheFly
- 3 days ago - Pulse Biosciences Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Pulse Biosciences Quarterly report: Q3 2026 - Filings
- 3 days ago - Pulse Biosciences Earnings release: Q3 2026 - Filings